Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Equity (2016 - 2025)

Rocket Pharmaceuticals' Return on Equity history spans 10 years, with the latest figure at 0.78% for Q4 2025.

  • For Q4 2025, Return on Equity fell 11.0% year-over-year to 0.78%; the TTM value through Dec 2025 reached 0.78%, down 11.0%, while the annual FY2025 figure was 0.62%, 6.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.78% at Rocket Pharmaceuticals, down from 0.74% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.31% in Q1 2021 and bottomed at 0.78% in Q4 2025.
  • The 5-year median for Return on Equity is 0.54% (2022), against an average of 0.54%.
  • The largest annual shift saw Return on Equity increased 2bps in 2021 before it dropped -20bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.36% in 2021, then crashed by -46bps to 0.52% in 2022, then rose by 4bps to 0.5% in 2023, then tumbled by -36bps to 0.67% in 2024, then fell by -16bps to 0.78% in 2025.
  • Per Business Quant, the three most recent readings for RCKT's Return on Equity are 0.78% (Q4 2025), 0.74% (Q3 2025), and 0.69% (Q2 2025).